GlaxoSmithKline (GSK) has signed multi-year, multi-million dollar contracts covering Licensing and Study Support Services with Phase Forward, a provider of data management solutions for clinical trials and drug safety. (Diane Fuell, Vice President of Business Support in the Centre for Clinical Study Excellence Operations and Data Quality at GSK.)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment